Skip to main content
. Author manuscript; available in PMC: 2015 Feb 20.
Published in final edited form as: AIDS. 2014 Feb 20;28(4):589–598. doi: 10.1097/QAD.0000000000000143

Figure 2. Cumulative incidence of outcomes on antiretroviral therapy (ART) since the introduction of Option B+.

Figure 2

The panels show the cumulative incidence of treatment outcomes over time from the start of antiretroviral therapy in months. Treatment outcomes are compared across three groups based on patients’ indication for ART: Option B+ indication and ART start during pregnancy (A), Option B+ indication and ART start after delivery while breastfeeding (B), and WHO stage 3 or 4 and/or CD4≤350/μL (C). Estimates are derived from competing risk regression.